Effect of Mobile Application on Urinary Incontinence
Launched by ESKISEHIR OSMANGAZI UNIVERSITY · Jun 1, 2022
Trial Information
Current as of November 09, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
This study tests whether a smartphone app called “My Fight with Incontinence” can help women with urinary incontinence (leakage) reduce symptoms, improve how well they do pelvic floor (Kegel) exercises, and boost quality of life. It is a randomized, single-blind trial (women don’t know their group) that compares 3 months of using the app with usual care versus a control group that receives a training booklet. Researchers will measure changes in leakage severity and related symptoms at 6 and 12 weeks, as well as impact on daily life, Kegel exercise adherence, and overall well-being. The study is being done at Eskişehir Osmangazi University in Turkey, and about 96 adult women are planned to participate.
To be eligible, you would need to be a female aged 18–65 with urinary incontinence (stress, urge, or mixed type), have an Android smartphone, be literate, and have a body mass index (BMI) under 30. You must consent to participate and not have certain exclusions, such as recent pelvic surgery or childbirth within the last several weeks, significant physical or mental disabilities, or other conditions that would make participation difficult. If enrolled, you’ll be randomly assigned to either the app group or the control group and will complete questionnaires at baseline, 6 weeks, and 12 weeks to track symptoms, exercise use, beliefs about urinary health, and quality of life. Results from this trial are not available yet.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Volunteer to participate in the research
- • Being a female
- • Being in the age range of 18-65
- • Using a smart mobile phone (for communicating via Whatsapp and installing a mobile application to the workgroup)
- • BMI \< 30kg/m2
- • Being literate
- • Having a diagnosis of urinary incontinence (stress, emergency/urge, mixed type)
- Exclusion Criteria:
- • Those who do not have an Android-based smartphone
- • Have a physical or mental disability
- • Those who have undergone vaginal and pelvic operations within 6 months
- • Have given birth within 12 weeks
- • Having a history of miscarriage within 6 weeks
- • Those who have had recurrent vaginitis infections
- • History of the cardiac implant or untreated cardiac arrhythmia
- • Having a communication barrier
About Eskisehir Osmangazi University
Eskisehir Osmangazi University is a distinguished academic institution dedicated to advancing medical research and education. With a commitment to enhancing healthcare outcomes, the university actively sponsors clinical trials that explore innovative therapeutic approaches and contribute to the scientific community. Leveraging its state-of-the-art facilities and a team of experienced researchers, Eskisehir Osmangazi University fosters collaboration across disciplines to address pressing health challenges and improve patient care. Through its rigorous research initiatives, the university aims to translate findings into practical applications that benefit both local and global populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Eskişehir, Odunpazarı, Turkey
Eskişehir, Turkey
Patients applied
Trial Officials
Pınar Duru, PhD
Principal Investigator
Department of Public Health Nursing, Eskisehir Osmangazi University, Turkey
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials